Melanoma
Bristol Myers Squibb’s Opdivo gets FDA approval for early-stage melanoma
Anika Sharma
Bristol Myers Squibb’s Opdivo has achieved a significant milestone with a new FDA approval that expands its reach into earlier ...
Scancell’s DNA vaccine shows promising results in phase 2 trial for skin cancer
Anika Sharma
Scancell’s shareholders are enjoying a prosperous week as the biotech company’s stock surged by 20%, driven by promising preliminary data ...
Iovance’s cell therapy for skin cancer faces three-year delay due to FDA issues
Anika Sharma
The FDA has introduced a new twist in the ongoing Iovance Biotherapeutics saga, causing further delays in the approval process ...
Ultimovacs Explores Innovative Approaches to Conclude Phase 2 Cancer Trial Amid Prolonged Anticipation for Survival Data
Anika Sharma
Ultimovacs, a Norwegian biotech company, is grappling with prolonged delays in obtaining midphase melanoma trial data, prompting the company to ...
Promising Early Antitumor Activity of Camrelizumab Plus Famitinib in Advanced Melanoma
SG Tylor
A Phase II trial presented at the 2023 ASCO Annual Meeting showed that combining the PD-L1 inhibitor camrelizumab with the ...
